MedCity News November 24, 2025
Dr. Iftach Dolev, a neuroscientist and CEO of QuantalX, explained how his company’s new FDA-cleared de novo device can bring a powerful tool to psychiatrists and neurologists alike. He claims this marks an important moment for brain health.
Most people think of brain health in terms of MRI and CT scans, but QuantalX is marrying transcranial magnetic stimulation with EEG such that clinicians can now measure individual brain function against QuantalX’s database of healthy brains and monitor changes over time. Both neurologists and psychiatrists can benefit from the device and associated software as a medical device, said Dr. Iftach Dolev, CEO of the company, in the MedCity Pivot Podcast. The company’s Delphi-MD device recently won a de novo FDA clearance.
...Today's Sponsors
Today's Sponsor